Slowing Tecfidera Sales Increases Biogen's (BIIB) M&A Risk - Moody's
Go back to Slowing Tecfidera Sales Increases Biogen's (BIIB) M&A Risk - Moody's| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 208.46 -7.66 (3.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.12 | 52 Week High | $333.65 | |||
| Open | $215.95 | 52 Week Low | $223.02 | |||
| Day High | $215.95 | P/E | 26.69 | |||
| Day Low | $208.27 | EPS | $7.81 | |||
| Volume | 1,218,473 | |||||

